Glioblastoma multiforme - disease overview considering sports and neurorehabilitation
DOI:
https://doi.org/10.12775/QS.2024.30.55575Keywords
glioblastoma multiforme, glioblastoma, CNS tumorAbstract
The brain is the most important organ, coordinating the work of the entire body. However, even it sometimes makes mistakes. Mutations in its genetic material can lead to the development of one of the most aggressive cancers - glioblastoma multiforme.
Glioblastoma multiforme is the most common primary malignant tumor of the central nervous system (CNS). According to the WHO, it is classified as grade 4 in terms of malignancy. The 5-year survival rate is 7.2%. Occurs worldwide with a frequency of less than 10 cases per 100,000 inhabitants. It is more common in men than in women, with an average age at diagnosis of 65 years. The primary confirmed risk factor is exposure to ionizing radiation. Despite advances in medical research, the prognosis for individuals with glioblastoma multiforme remains unfavorable. The median survival time remains around 15 months.
This article provides an overview of glioblastoma multiforme, including its etiology, symptoms, diagnosis, and treatment. By elucidating the current state of knowledge on glioblastoma multiforme, this work aims to facilitate early detection, treatment, and raise awareness among both physicians and patients about the disease. [7,14,17]
References
Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM. Sleep-wake disturbance in patients with brain tumors. Neuro Oncol. 2017 Mar 1;19(3):323-335. doi: 10.1093/neuonc/now119. PMID: 27286798; PMCID: PMC5464298.
Berthold D, Carrasco AP, Uhl E, Müller H, Dumitrascu R, Sibelius U, Hauch H. Palliative care of older glioblastoma patients in neurosurgery. J Neurooncol. 2022 Apr;157(2):297-305. doi: 10.1007/s11060-022-03985-x. Epub 2022 Mar 24. PMID: 35332410; PMCID: PMC9021091.
Biserova K, Jakovlevs A, Uljanovs R, Strumfa I. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma. Cells. 2021 Mar 11;10(3):621. doi: 10.3390/cells10030621. PMID: 33799798; PMCID: PMC8000844.
Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA; Brain Tumor Epidemiology Consortium. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008 Oct 1;113(7 Suppl):1953-68. doi: 10.1002/cncr.23741. PMID: 18798534; PMCID: PMC2861559.
Broekman ML, Maas SLN, Abels ER, Mempel TR, Krichevsky AM, Breakefield XO. Multidimensional communication in the microenvirons of glioblastoma. Nat Rev Neurol. 2018 Aug;14(8):482-495. doi: 10.1038/s41582-018-0025-8. PMID: 29985475; PMCID: PMC6425928.
Coronatto LH, Formentin C. Palliative care in glioblastoma patients: a systematic review. Rev Assoc Med Bras (1992). 2024 Jun 7;70(suppl 1). doi: 10.1590/1806-9282.2024S122. PMID: 38865542; PMCID: PMC11164275.
Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, Kościński J, Graczyk P, Hałas T, Lewandowska AM, Czepczyński R, Ruchała M. Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques. Pharmacology. 2023;108(5):423-431. doi: 10.1159/000531319. Epub 2023 Jul 17. PMID: 37459849.
Davis ME. Glioblastoma: Overview of Disease and Treatment. Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl). doi: 10.1188/16.CJON.S1.2-8. PMID: 27668386; PMCID: PMC5123811.
Ertürk Çetin Ö, İşler C, Uzan M, Özkara Ç. Epilepsy-related brain tumors. Seizure. 2017 Jan;44:93-97. doi: 10.1016/j.seizure.2016.12.012. Epub 2016 Dec 21. PMID: 28041673.
Finze A, Deleanu L, Weiss C, Ratliff M, Seiz-Rosenhagen M. Depression in brain tumor patients-early detection and screening. Support Care Cancer. 2023 May 16;31(6):339. doi: 10.1007/s00520-023-07785-5. PMID: 37191815; PMCID: PMC10188424.
Hu S, Kang H, Baek Y, El Fakhri G, Kuang A, Choi HS. Real-Time Imaging of Brain Tumor for Image-Guided Surgery. Adv Healthc Mater. 2018 Aug;7(16). doi: 10.1002/adhm.201800066. Epub 2018 May 2. PMID: 29719137; PMCID: PMC6105507.
Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H. Current Immunotherapies for Glioblastoma Multiforme. Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. PMID: 33767690; PMCID: PMC7986847.
Kim JY, Peters KB, Herndon JE 2nd, Affronti ML. Utilizing a Palliative Care Screening Tool in Patients With Glioblastoma. J Adv Pract Oncol. 2020 Sep-Oct;11(7):684-692. doi: 10.6004/jadpro.2020.11.7.3. Epub 2020 Sep 1. PMID: 33575065; PMCID: PMC7646633.
Khabibov M, Garifullin A, Boumber Y, Khaddour K, Fernandez M, Khamitov F, Khalikova L, Kuznetsova N, Kit O, Kharin L. Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review). Int J Oncol. 2022 Jun;60(6):69. doi: 10.3892/ijo.2022.5359. Epub 2022 Apr 21. PMID: 35445737; PMCID: PMC9084550.
Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE, Forst DA, Jalali R, Oliver K, Philip J, Taphoorn MJB, Dirven L, Walbert T. Palliative care and end-of-life care in adults with malignant brain tumors. Neuro Oncol. 2023 Mar 14;25(3):447-456. doi: 10.1093/neuonc/noac216. Erratum in: Neuro Oncol. 2023 Jan 5;25(1):212. doi: 10.1093/neuonc/noac252. PMID: 36271873; PMCID: PMC10013651.
Lah TT, Novak M, Breznik B. Brain malignancies: Glioblastoma and brain metastases. Semin Cancer Biol. 2020 Feb;60:262-273. doi: 10.1016/j.semcancer.2019.10.010. Epub 2019 Oct 22. PMID: 31654711.
Mahmoud AB, Ajina R, Aref S, Darwish M, Alsayb M, Taher M, AlSharif SA, Hashem AM, Alkayyal AA. Advances in immunotherapy for glioblastoma multiforme. Front Immunol. 2022 Oct 12;13:944452. doi: 10.3389/fimmu.2022.944452. PMID: 36311781; PMCID: PMC9597698.
Martinez NL, Glass J, Shi W. Bevacizumab in recurrent glioblastoma. Transl Cancer Res. 2019 Mar;8(Suppl 2). doi: 10.21037/tcr.2018.12.33. PMID: 35117090; PMCID: PMC8797887.
Nilsson M, Englund E, Szczepankiewicz F, van Westen D, Sundgren PC. Imaging brain tumour microstructure. Neuroimage. 2018 Nov 15;182:232-250. doi: 10.1016/j.neuroimage.2018.04.075. Epub 2018 May 8. PMID: 29751058.
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 2014 Jul;16(7):896-913. doi: 10.1093/neuonc/nou087. PMID: 24842956; PMCID: PMC4057143.
Ostrom QT, Adel Fahmideh M, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, Bondy ML. Risk factors for childhood and adult primary brain tumors. Neuro Oncol. 2019 Nov 4;21(11):1357-1375. doi: 10.1093/neuonc/noz123. PMID: 31301133; PMCID: PMC6827837.
Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Rudà R, Marosi C, Le Rhun E, Grant R, Oliver K, Oberg I, Bulbeck HJ, Rooney AG, Henriksson R, Pasman HRW, Oberndorfer S, Weller M, Taphoorn MJB; European Association of Neuro-Oncology palliative care task force. European Association for Neuro-Oncology (EAANO) guidelines for palliative care in adults with glioma. Lancet Oncol. 2017 Jun;18(6). doi: 10.1016/S1470-2045(17)30345-5. PMID: 28593859.
Parada LF, Dirks PB, Wechsler-Reya RJ. Brain Tumor Stem Cells Remain in Play. J Clin Oncol. 2017 Jul 20;35(21):2428-2431. doi: 10.1200/JCO.2017.73.9540. Epub 2017 Jun 22. PMID: 28640710; PMCID: PMC5516484.
Perkins A, Liu G. Primary Brain Tumors in Adults: Diagnosis and Treatment. Am Fam Physician. 2016 Feb 1;93(3):211-7. PMID: 26926614.
Rodríguez-Camacho A, Flores-Vázquez JG, Moscardini-Martelli J, Torres-Ríos JA, Olmos-Guzmán A, Ortiz-Arce CS, Cid-Sánchez DR, Pérez SR, Macías-González MDS, Hernández-Sánchez LC, Heredia-Gutiérrez JC, Contreras-Palafox GA, Suárez-Campos JJE, Celis-López MÁ, Gutiérrez-Aceves GA, Moreno-Jiménez S. Glioblastoma Treatment: State-of-the-Art and Future Perspectives. Int J Mol Sci. 2022 Jun 29;23(13):7207. doi: 10.3390/ijms23137207. PMID: 35806212; PMCID: PMC9267036.
Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T. Glioblastom hos voksne [Glioblastoma in adults]. Tidsskr Nor Laegeforen. 2023 Jan 30;143(2). Norwegian. doi: 10.4045/tidsskr.22.0314. PMID: 36718891.
Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N. Current Challenges and Opportunities in Treating Glioblastoma. Pharmacol Rev. 2018 Jul;70(3):412-445. doi: 10.1124/pr.117.014944. PMID: 29669750; PMCID: PMC5907910.
Sharma S, Hashmi MF, Davidson CL, Kumar A. Intracranial Hypertension. 2024 Mar 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29939588.
Shukla G, Alexander GS, Bakas S, Nikam R, Talekar K, Palmer JD, Shi W. Advanced magnetic resonance imaging in glioblastoma: a review. Chin Clin Oncol. 2017 Aug;6(4):40. doi: 10.21037/cco.2017.06.28. PMID: 28841802.
Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020 Jul;70(4):299-312. doi: 10.3322/caac.21613. Epub 2020 Jun 1. PMID: 32478924.
Villanueva-Meyer JE, Mabray MC, Cha S. Current Clinical Brain Tumor Imaging. Neurosurgery. 2017 Sep 1;81(3):397-415. doi: 10.1093/neuros/nyx103. PMID: 28486641; PMCID: PMC5581219.
Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY, Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G, Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D, Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent MJ. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106. PMID: 32328653; PMCID: PMC7594557.
Zienius K, Chak-Lam I, Park J, Ozawa M, Hamilton W, Weller D, Summers D, Porteous L, Mohiuddin S, Keeney E, Hollingworth W, Ben-Shlomo Y, Grant R, Brennan PM. Direct access CT for suspicion of brain tumour: an analysis of referral pathways in a population-based patient group. BMC Fam Pract. 2019 Aug 20;20(1):118. doi: 10.1186/s12875-019-1003-y. PMID: 31431191; PMCID: PMC6702708.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Monika Niedźwiedzka, Kamila Rosińska, Julia Natalia Łojewska, Ewelina Justyna Janicka , Agnieszka Perko , Mateusz Rosiński, Marta Mocarska-Aniśko
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 103
Number of citations: 0